A medium-term plan theme in which 4569 is pursuing 5 business strategies under Vision 110 Stage 1: new drug creation capabilities, an in-licensed pipeline, the ratio of new drugs, health-related businesses, and a sustainable corporate platform. In Stage 2, it aims to expand its development pipeline through active investment in in-licensing.